Enovis (ENOV) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -1,135.00 |
| Dec 31, 2025 | -7,109.00 |
| Oct 3, 2025 | -10,778.00 |
| Jul 4, 2025 | 81.00 |
| Apr 4, 2025 | -1,296.00 |
| Dec 31, 2024 | -12,676.00 |
| Sep 27, 2024 | -872.00 |
| Jun 28, 2024 | -613.00 |
| Mar 29, 2024 | -1,250.00 |
| Dec 31, 2023 | -26.00 |
| Sep 29, 2023 | -1,057.00 |
| Jun 30, 2023 | -1,112.00 |
| Mar 31, 2023 | -1,448.00 |
| Dec 31, 2022 | 1,396.00 |
| Sep 30, 2022 | -2,791.00 |
| Jul 1, 2022 | 2,220.00 |
| Apr 1, 2022 | -1,699.00 |
| Dec 31, 2021 | -1,282.00 |
| Oct 1, 2021 | -1,238.00 |
| Jul 2, 2021 | -2,054.00 |
| Apr 2, 2021 | 632.00 |
| Dec 31, 2020 | -1,690.00 |
| Oct 2, 2020 | 93.00 |
| Jul 3, 2020 | -1,338.00 |
| Apr 3, 2020 | -448.00 |
| Dec 31, 2019 | -137.00 |
| Sep 27, 2019 | -864.00 |
| Jun 28, 2019 | -592.00 |
| Mar 29, 2019 | -1,000.00 |
| Dec 31, 2018 | -445.00 |
| Sep 28, 2018 | -394.00 |
| Jun 29, 2018 | -210.00 |
| Mar 30, 2018 | 192.00 |
| Dec 31, 2017 | -1,739.00 |
| Sep 29, 2017 | 457.00 |
| Jun 30, 2017 | 396.00 |
| Mar 31, 2017 | 1,181.00 |
| Dec 31, 2016 | 1,171.00 |
| Sep 30, 2016 | 428.00 |
| Jul 1, 2016 | -51.00 |
| Apr 1, 2016 | -86.00 |
| Dec 31, 2015 | -1,129.00 |
| Sep 25, 2015 | -175.00 |
| Jun 26, 2015 | 542.00 |